Editorial
Editorial on “Can CT-PET and endoscopic assessment post-neoadjuvant chemoradiotherapy predict residual disease in esophageal cancer”
Abstract
Neoadjuvant chemoradiation (nCRT) followed by surgery is the most common treatment modality for resectable esophageal cancer nowadays (1). Esophagectomy and gastrointestinal continuity reconstruction are extensive and challenging procedures (2).
